• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Mirion Technologies Inc.

    12/18/24 8:24:51 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials
    Get the next $MIR alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 9)*


    Mirion Technologies, Inc.

    (Name of Issuer)


    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    60471A101

    (CUSIP Number)


    Philip Grovit
    GSAM Holdings LLC, 200 West Street
    New York, NY, 10282
    212-859-8000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    12/17/2024

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    60471A101


    1 Name of reporting person

    GSAM Holdings LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    5,131,020.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    5,131,020.00
    11Aggregate amount beneficially owned by each reporting person

    5,131,020.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    2.3 %
    14Type of Reporting Person (See Instructions)

    OO



    SCHEDULE 13D

    CUSIP No.
    60471A101


    1 Name of reporting person

    GOLDMAN SACHS GROUP INC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    5,187,419.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    5,187,419.00
    11Aggregate amount beneficially owned by each reporting person

    5,187,419.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    2.3 %
    14Type of Reporting Person (See Instructions)

    CO, HC



    SCHEDULE 13D

    CUSIP No.
    60471A101


    1 Name of reporting person

    GOLDMAN SACHS & CO. LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    5,187,419.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    5,187,419.00
    11Aggregate amount beneficially owned by each reporting person

    5,187,419.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    2.3 %
    14Type of Reporting Person (See Instructions)

    CO, HC



    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A Common Stock, par value $0.0001 per share
    (b)Name of Issuer:

    Mirion Technologies, Inc.
    (c)Address of Issuer's Principal Executive Offices:

    1218 Menlo Drive, Atlanta, GEORGIA , 30318.
    Item 1 Comment:
    This Amendment (this "Amendment No. 9"), which relates to the Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), of Mirion Technologies, Inc., a Delaware corporation (the "Issuer"), further amends the initial Schedule 13D (as amended prior to the date hereof, the "Initial Filing"), of GSAM Holdings LLC ("Holdings"), GS Sponsor II LLC ("Sponsor"), Goldman Sachs & Co. LLC ("Goldman Sachs") and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, the "Reporting Persons"). Each of Holdings and Sponsor previously reported that it had ceased to be a beneficial owner of more than 5% of the outstanding shares of Class A Common Stock. Holdings is included in the cover pages of this Amendment No. 9 solely for technical reasons. Disclosure items set forth in the Initial Filing shall remain in effect with respect to the Reporting Persons except to the extent expressly amended or superseded by this Amendment No. 9. All capitalized terms used and not expressly defined in this Amendment No. 9 have the respective meanings ascribed to such terms in the Initial Filing.
    Item 4.Purpose of Transaction
     
    Item 4 is hereby amended by the addition of the following: On December 17, 2024, the vesting conditions were satisfied in respect of the last of three tranches of the Founder Shares of Class A Common Stock previously reported in the Initial Filing. In connection with such vesting, Employee Participation 1 LLC distributed 441,668 shares of Class A Common Stock to its members and Employee Participation 2 LLC distributed 466,684 shares of Class A Common Stock to its members, in each case for no consideration. Further upon such vesting, Sponsor distributed 5,341,655 shares of Class A Common Stock to its members for no consideration. Each of Goldman Sachs and GS Group ceased to beneficially own such shares of Class A Common Stock upon such distributions, except for 2,668,329 shares of Class A Common Stock distributed to Holdings. Additionally, on December 18, 2024, the Reporting Persons caused Holdings to make a charitable contribution of 2,201,980 shares of Class A Common Stock.
    Item 5.Interest in Securities of the Issuer
    (a)
    The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D gives effect to the share distributions described in Item 4 and is incorporated by reference into this Item 5. The percentage beneficial ownership reported herein by each Reporting Person is based on 225,500,094 shares of Class A Common Stock outstanding as of October 25, 2024, as reflected in the Form 10-Q filed by the Issuer with the SEC on October 30, 2024. Each of Goldman Sachs and GS Group may be deemed to beneficially own 5,187,419 shares of Class A Common Stock, constituting 2.3% of the outstanding shares of Class A Common Stock. Each of Goldman Sachs and GS Group may be deemed to have shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, (i) 5,131,020 shares of Class A Common Stock held by Holdings and (ii) 56,399 shares of Class A Common Stock held by certain subsidiaries of GS Group in the ordinary course of business in order to facilitate the investing activity of their clients.
    (b)
    The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D gives effect to the share distributions described in Item 4 and is incorporated by reference into this Item 5. The percentage beneficial ownership reported herein by each Reporting Person is based on 225,500,094 shares of Class A Common Stock outstanding as of October 25, 2024, as reflected in the Form 10-Q filed by the Issuer with the SEC on October 30, 2024. Each of Goldman Sachs and GS Group may be deemed to beneficially own 5,187,419 shares of Class A Common Stock, constituting 2.3% of the outstanding shares of Class A Common Stock. Each of Goldman Sachs and GS Group may be deemed to have shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, (i) 5,131,020 shares of Class A Common Stock held by Holdings and (ii) 56,399 shares of Class A Common Stock held by certain subsidiaries of GS Group in the ordinary course of business in order to facilitate the investing activity of their clients.
    (c)
    Except as described in Item 4, including the completion of the distributions described in Item 4 as set forth in Amendment No. 8, neither the Reporting Persons nor, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A, Schedule B or Schedule C, effected any transactions in the Class A Common Stock since the date of Amendment No. 8 other than a charitable contribution of 1,207,000 shares of Class A Common Stock by Holdings on November 26, 2024.
    (d)
    Not Applicable
    (e)
    On December 18, 2024, upon the completion of the distributions and contribution described above in Item 4, each of Goldman Sachs and GS Group ceased to be a beneficial owner or more than five percent of the outstanding Class A Common Stock.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    GSAM Holdings LLC
     
    Signature:/s/ N/A
    Name/Title:N/A
    Date:12/18/2024
     
    GOLDMAN SACHS GROUP INC
     
    Signature:/s/ Crystal Orgill
    Name/Title:Crystal Orgill, Attorney-in-Fact
    Date:12/18/2024
     
    GOLDMAN SACHS & CO. LLC
     
    Signature:/s/ Crystal Orgill
    Name/Title:Crystal Orgill, Attorney-in-Fact
    Date:12/18/2024
    Get the next $MIR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MIR

    DatePrice TargetRatingAnalyst
    12/19/2024$22.00Outperform
    Robert W. Baird
    9/26/2024$14.00Buy
    B. Riley Securities
    5/26/2023$11.00Buy
    Citigroup
    3/24/2022$13.00Market Outperform
    CJS Securities
    11/29/2021$14.00Buy
    Goldman Sachs
    10/25/2021$14.00Buy
    Citigroup
    More analyst ratings

    $MIR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

      Apex-Guard™ Software Version 1.2 Introduces Robust Impurity Analysis for Enhanced Radioisotope Quality Mirion Technologies (NYSE:MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces the Mirion commitment to improving quality in cancer care, through focused innovation across its Mirion Technologies and Mi

      4/1/25 4:03:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    SEC Filings

    See more
    • SEC Form 10-Q filed by Mirion Technologies Inc.

      10-Q - Mirion Technologies, Inc. (0001809987) (Filer)

      4/30/25 4:21:46 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Mirion Technologies, Inc. (0001809987) (Filer)

      4/29/25 4:21:26 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • SEC Form DEFA14A filed by Mirion Technologies Inc.

      DEFA14A - Mirion Technologies, Inc. (0001809987) (Filer)

      4/1/25 4:44:03 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Financials

    Live finance-specific insights

    See more

    $MIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $MIR
    Leadership Updates

    Live Leadership Updates

    See more

    $MIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Record Fourth Quarter and Record Full Year 2024 Financial Results; Reaffirms Full Year 2025 Guidance

       Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece

      2/11/25 4:05:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Robert W. Baird initiated coverage on Mirion Technologies with a new price target

      Robert W. Baird initiated coverage of Mirion Technologies with a rating of Outperform and set a new price target of $22.00

      12/19/24 7:44:58 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • B. Riley Securities initiated coverage on Mirion Technologies with a new price target

      B. Riley Securities initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00

      9/26/24 7:38:28 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Citigroup resumed coverage on Mirion Technologies with a new price target

      Citigroup resumed coverage of Mirion Technologies with a rating of Buy and set a new price target of $11.00

      5/26/23 7:18:55 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Mirion Technologies Inc.

      SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/14/24 1:28:33 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/13/24 6:42:31 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/6/24 6:59:38 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

      SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

      9/29/23 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Janus International Appoints David Vanevenhoven as Chief Accounting Officer

      Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control

      2/21/23 7:00:00 AM ET
      $JBI
      $MIR
      Building Products
      Industrials
      Industrial Machinery/Components
    • Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

      Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le

      10/3/22 8:00:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Schopfer Brian covered exercise/tax liability with 14,801 shares, decreasing direct ownership by 2% to 883,427 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:26:18 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Executive Officer Logan Thomas D covered exercise/tax liability with 54,143 shares, decreasing direct ownership by 1% to 3,943,501 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:24:25 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Human Resources Officer Ulrich Alison covered exercise/tax liability with 2,859 shares, decreasing direct ownership by 8% to 35,230 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:22:48 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials